Armstrong Mac sold $484K of PLMR (indirect holdings)

Armstrong Mac (CEO and Chairman) sold 3,500 indirectly-held shares of Palomar Holdings, Inc. (PLMR) at an average of $138.31 ($137.60–$139.25, $0.48M total) across 3 trades on 2026-10-21 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Armstrong Mac
Published Oct 22, 2026, 8:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 22, 2026, 8:18 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$PLMR
Bearish
medium confidence
Mentioned
$PLMR
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PLMRBearishLow
01

Why it matters

The disclosed sale is small relative to market cap, likely causing only minor price movement.

02

Market read

A routine insider sale with limited trading relevance.

03

What to watch

Potential upcoming corporate actions or financing needs not disclosed in the filing.

Relevance 3/10Novelty 3/10Timing: after market today

Background

SEC Form 4 filing discloses insider transactions for public companies.

Company-level read

Ticker impact

$PLMRBearishMedium confidence
Context

CEO Armstrong Mac sold 3,500 PLMR shares for $484,097 via a 10b5-1 plan, reducing his stake to 315,388 shares.

Expected impact

likely slight downward pressure as the market prices in the insider sell.

Evidence & confidence

The transaction size is modest ($0.5M) and disclosed via a Form 4, so impact is limited but may signal short‑term weakness.

Market effects

Minimal effect on the broader biotech sector.

No regional impact.

Limited to PLMR investors.

Counterpoint

The sale could be routine under a pre‑arranged plan and not indicate any negative fundamentals.

Key entities

  • Palomar Holdings, Inc.

    Biotech firm listed on NASDAQ under ticker PLMR.

  • Armstrong Mac

    CEO and Chairman of Palomar Holdings.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$PLMRHighAI 8/10

Palomar Holdings, Inc. (PLMR): Investor Presentation November 2026

Palomar Holdings, Inc. (PLMR) filed an SEC Form 8-K — Regulation FD Disclosure. Investor Presentation November 2026 Disclaimer This presentation contains forward-looking statements about Palomar Holdings, Inc. (the “Company”). These statements involve known and unknown risks that relate to the Company’s future events or future financial performance and the a

$PLMRHigh

Keefe Bruyette raises Palomar Holdings stock price target on earnings beat

Keefe Bruyette & Woods raised its price target for Palomar Holdings (PLMR) to $172 from $161, citing strong Q3 2026 earnings and updated financial estimates. The firm expects lower core loss ratios and faster net investment income growth. PLMR reported adjusted EPS of $3.01, beating estimates, and raised its full-year adjusted net income guidance. Truist Securities also increased its price target to $175.

$PLMRMed

Palomar Q3 Earnings Call Highlights

Palomar (PLMR) reported Q3 earnings, with CFO Chris Uchida noting $425M in crop premiums and confidence in reaching a $500M intermediate goal. CEO Armstrong highlighted growth in earthquake, inland marine, and property premiums, despite commercial rate pressure. The company's adjusted combined ratio was 76.3%, up from 74.8% YoY, with a total loss ratio of 41.5%. Palomar expects continued growth and capital returns, including dividends and stock repurchases.

$PLMRHighAI 8/10

Palomar Holdings Inc (PLMR) (Q3 2026) Earnings Call Highlights: Record Premium, 16th

Palomar Holdings Inc (PLMR) reported record Q3 2026 results with gross written premium up 28% YoY and adjusted net income of $81.3M. Adjusted EPS grew 50%, and the combined ratio was 76%. All product categories grew, with crop and surety leading. Guidance was raised to $280M-$285M for full-year adjusted net income. Challenges include decelerated casualty growth and catastrophe losses.

$PLMRMed

Truist raises Palomar Holdings stock price target on earnings growth

Truist Securities raised its price target on Palomar Holdings (PLMR) to $175 from $168, citing earnings growth and strong fundamentals. The stock trades at $153.07 with a market cap of $4.04B. Truist also increased its 2026 and 2027 EPS estimates, noting revenue growth of 58% and a 23% return on equity. Palomar reported Q3 2026 earnings of $3.01 per share, beating estimates.